To identify IL-8-associated new potential therapeutic targets, we next focused on the underlying in vitro molecular mechanism leading to SPTAN1-dependent enhanced IL-8 expression and secretion using different CRC cell line models that mimick the described special CRC phenotype. Here, SPTAN1 is linked to colorectal carcinoma.